Stoma, ostomy, wound and fistula Injury, Occupational Diseases, Poisoning Stoma, ostomy, wound and fistula
Conditions
Interventions
The trial is a randomised cross over trial. Patients will be assigned a patient identity number and will then be randomly
assigned either to begin with their normal pouching regime or their normal po
Sponsors
T G Eakin Limited (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients presenting wounds, stomas and fistulae with greater than 200 ml exudate per day.
Exclusion criteria
Exclusion criteria: Patients will be excluded from the study under the following circumstances: 1. Where informed consent is withheld 2. Where the patient is unable to give informed consent due to legal incompetence 3. Where, in the physician's opinion, inclusion in the trial is not advised 4. Where the patient is presenting a critical wound, or is in an emergency situation 5. Where the patient is in the intensive care unit 6. Where there is an open wound in the peristomal region (for stoma patients only) 7. Where the patient is currently participating in another clinical trial 8. Where the patient has a known sensitivity to the product or any of its ingredients 8. Where the patient currently uses stoma paste as part of their regular pouching regime
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Confirmation of the safety and efficacy of Eakin cohesive paste | — |
Secondary
| Measure | Time frame |
|---|---|
| Determination of whether Eakin cohesive paste increases the pouch weartime on high output wounds. | — |
Countries
United Kingdom
Outcome results
None listed